ISSN Online:2229-3566
ISSN Print: 2277-4343
Article: MARKER PARAMETERS FOR PHARMACOGNOSTICAL EVALUATION OF CONTROVERSIAL PLANTS VIS-A-VIS MOORVA
Article Category: Original Research articles
DOI: 10.7897/2277-4343.110223
Pages: 15-21
Author: Sevantika Rotti *, P. Subrahmanya
Abstract: The plant Moorva is found as Jwarahara plant as mentioned in Brihatrayees, Laghutrayees and Nighantu literatures of Ayurveda. Moorva is a controversial plant and many plants are being used in the name of Moorva. Pharmacognosy research study becomes an important role in identification of controversial plants. The reasons for controversy could be either different plants of different region are often known by common name, several names for one plant or commercial substitution in non-availability of classical drug with local drug. The genuine basic raw material is very much essential for good quality medicines. Present study aims to define standards for identifying three source plants of Moorva botanically and chemically. Morphological evaluation carried out by qualitative evaluation based on morphological and sensory profile. Microscopical evaluation done for histological characters by using microscope and micro photography By Chemo-microscopy chemical method, evaluation is done with powders of plants. Preliminary phytochemical screening is done by qualitative chemical tests for establishing chemical profile. Chromatography study is performed by adsorption chromatography method. Three plants showed different cell structures, cell contents and different physical standards and phytochemicals. TLC shows presence of different phytoconstituents with different bands. Differentiation in cell, cell content, presence of phytoconstituents and different bands with TLC suggests, the three source plants have their different diagnostic value. Three source plants of Moorva have different marker parameters.
Keyword: Antipyretic, Chonemorpha macrophylla- G. Don, Clematis triloba- A. St. Hill, Controversy, Moorva, Maeruaarenaria- Hook f and Thoms, Jwara, Pharmacognosy, TLC.